Sarepta Therapeutics To Announce Fourth Quarter And Full-Year 2025 Financial Results
Sarepta Therapeutics, Inc. will announce its fourth quarter and full-year 2025 financial results on February 25, 2026, after the Nasdaq closes. A conference call will follow at 4:30 p.m. E.T. to discuss the results, which will be webcast live on the company's website. Sarepta focuses on precision genetic medicine for rare diseases, particularly Duchenne muscular dystrophy, and maintains an active investor relations section on its website for updates.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments